|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-1-23
|
|
pubmed:abstractText |
The aim of secondary prevention in stroke is to avoid restrokes. The current standard treatment in Germany is a lifelong therapy with low-dose acetylsalicylic acid (ASA). As the incidence of restrokes remains relatively high from a health-care payer's perspective, the question arises, whether the combination of dipyridamole + acetylsalicylic acid (Dip + ASA) is cost-effective in comparison with a therapy based on ASA only.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0723-5003
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
778-87
|
|
pubmed:meshHeading |
pubmed-meshheading:19165429-Adult,
pubmed-meshheading:19165429-Aged,
pubmed-meshheading:19165429-Aged, 80 and over,
pubmed-meshheading:19165429-Aspirin,
pubmed-meshheading:19165429-Cause of Death,
pubmed-meshheading:19165429-Cerebral Infarction,
pubmed-meshheading:19165429-Cost Savings,
pubmed-meshheading:19165429-Cost-Benefit Analysis,
pubmed-meshheading:19165429-Cross-Sectional Studies,
pubmed-meshheading:19165429-Decision Support Techniques,
pubmed-meshheading:19165429-Dipyridamole,
pubmed-meshheading:19165429-Dose-Response Relationship, Drug,
pubmed-meshheading:19165429-Drug Administration Schedule,
pubmed-meshheading:19165429-Drug Costs,
pubmed-meshheading:19165429-Drug Therapy, Combination,
pubmed-meshheading:19165429-Female,
pubmed-meshheading:19165429-Germany,
pubmed-meshheading:19165429-Humans,
pubmed-meshheading:19165429-Incidence,
pubmed-meshheading:19165429-Long-Term Care,
pubmed-meshheading:19165429-Male,
pubmed-meshheading:19165429-Markov Chains,
pubmed-meshheading:19165429-Middle Aged,
pubmed-meshheading:19165429-National Health Programs,
pubmed-meshheading:19165429-Platelet Aggregation Inhibitors,
pubmed-meshheading:19165429-Recurrence,
pubmed-meshheading:19165429-Survival Rate
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].
|
|
pubmed:affiliation |
Forschungsstelle für Gesundheitsökonomie, Leibniz Universität Hannover, Hannover, Germany. cc@ivbl.uni-hannover.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
